Regencell Bioscience
3 hedge funds and large institutions have $156K invested in Regencell Bioscience in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$144K |
| 2 |
2
Morgan Stanley
New York
|
$10.4K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $144K | +$56K | +430,996 | +63% |
|
|
2
Morgan Stanley
New York
| $10.4K | +$10.4K | +79,800 | New |
|
3
BlackRock
New York
| $1.18K | – | – | – |
|